Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Contrast Media API Market: By Product Type, and Region Forecast 2019-2030
Contrast Media API Market size was valued at US$ 1,798.3 million in 2023 and is expected to grow at a CAGR of 4.2% from 2024 to 2030. In terms of volume, the contrast media API sales accounted for 11,127 tons (2023) of APIs in the global market. The increase in the prevalence of chronic diseases, technological advancements in medical imaging, and the increase in demand of invasive techniques are the key factors driving the market. Furthermore, the rising awareness about early disease diagnosis and the growing number of medical imaging procedures performed globally also drive the market growth of the contrast agents API market.
Market has very few market players even though their application across various disease diagnosis. The limited players coupled with the tight supply of contrast media API is predicted to create huge demand for the APIs in the last two years. For instance, In April 2022, GE healthcare shut their Shanghai manufacturing facility due to the COVID 19 outbreak that led to drug shortages of iohexol, and iodixanol formulations. To meet the growing demand company invested US$ 80 million to manufacture iodinated contrast agents API in their Norway facility in 2023 to produce 30 million more patient doses annually by 2025. In addition to that, company also opened new production line in Cork, Ireland facility.
The market reached an all-time high in 2022 and reached US$ 1.8 Billion owing to the tight supply and increase in the raw material iodine prices. The price level of iodine has increased from 2022, increased from US$ 35.88/kg at the starting of the year to a maximum of US$ 71.28/kg in August. In July 2023, the iodine price remained at a high level of more than US$ 60 /kg.
The market is mainly dominated by the innovator companies like GE, Bracco, Bayer, and Guerbet. In the generic space, most of the production takes place in Asia Pacific region mainly in China, followed by India, and South Korea. Currently, the major generic API manufacturers are Starry Pharma, Hichi Pharmaceutical, Brother Technology, Haizhou Pharmaceutical, Divis Laboratories, and others. Starry Pharma is the only contrast API manufacturer with large scale manufacturing of iodinated contrast agents across the globe. The company have manufacturing capacity close to the innovator companies.
Study Period
2024-2030Base Year
2023CAGR
4.2%Largest Market
Asia PacificFastest Growing Market
Asia Pacific
Increase in CT/X-ray, and MRI procedures are driving the growth of the contrast agents API Market across the globe. CT/X-Ray based contrast media API’s accounts to have more than 95% of market share in terms of volume and rest is MRI contrast media API’s. However, in terms of pricing, iodinated contrast agent’s API’s price ranges from USD 98- 300/kg whereas the MRI contrast agents API’ prices are USD 450 – 700/kg. MRI based contrast agent market is growing at a faster growth rates when compared with the iodinated contrast agents. Developed markets like North America and Europe dominated by the innovator formulations rather than the generic formulations. In Asia Pacific region, both innovator and generic formulations are used for the imaging diagnosis.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 1,798.3 million |
Market CAGR |
4.2% |
By Product Type |
|
By Region |
|
Download Free Sample Report
The contrast media api market size was valued at US$ 1,798.3 million in 2023 and is set to grow at a significant CAGR of 4.2% from 2024-2030.
In Production of API, Asia Pacific dominates the market. China is the leading country across the globe producing contrast media APIs followed by India. In China, Zhejiang Starry Pharmaceutical Co., Ltd is the only company with large scale iodinated API manufacturer.
GE, Divi’s Laboratories, Zhejiang Starry Pharmaceutical Co., Ltd, Brother Technology, Bracco (Innovator), Zhejiang Taizhou Hisyn Pharmaceutical, DongKook Pharmaceutical Co Ltd., Pfizer (Hospira), Hengrui Pharmaceuticals, Jiangsu Yutian Pharmaceuticals, Guerbet, Jiangsu Hengrui Pharmaceuticals, Haichang Pharmaceuticals, Bayer, Sichuan Renan Pharmaceuticals, and Daewoong Pharma.
Key factors that are driving the market growth include the increasing prevalence of long-term diseases and complex comorbidities, label expansions, and technology advancements.
1.Executive Summary |
2.Global Contrast Media API Market Introduction |
2.1.Global Contrast Media API Market - Taxonomy |
2.2.Global Contrast Media API Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Region |
3.Global Contrast Media API Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Contrast Media API Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Contrast Media API Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Iohexol |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Iopamidol |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Iodixanol |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Iopromide |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Ioversol |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Diatrizoic acid |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Gadoterate dimeglumine |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Gadobutrol |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Gadobenate dimeglumine Value |
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Gadoxetic Acid |
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
5.11. Gadobemedeglumine |
5.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.11.3. Market Opportunity Analysis |
6.Global Contrast Media API Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific (APAC) |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Middle East and Africa (MEA) |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Latin America |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.North America Contrast Media API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1.Iohexol |
7.1.2.Iopamidol |
7.1.3.Iodixanol |
7.1.4.Iopromide |
7.1.5.Ioversol |
7.1.6.Diatrizoic acid |
7.1.7.Gadoterate dimeglumine |
7.1.8.Gadobutrol |
7.1.9.Gadobenate dimeglumine Value |
7.1.10.Gadoxetic Acid |
7.1.11.Gadobemedeglumine |
7.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1.United States of America (USA) |
7.2.2.Canada |
8.Europe Contrast Media API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Iohexol |
8.1.2.Iopamidol |
8.1.3.Iodixanol |
8.1.4.Iopromide |
8.1.5.Ioversol |
8.1.6.Diatrizoic acid |
8.1.7.Gadoterate dimeglumine |
8.1.8.Gadobutrol |
8.1.9.Gadobenate dimeglumine Value |
8.1.10.Gadoxetic Acid |
8.1.11.Gadobemedeglumine |
8.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Germany |
8.2.2.France |
8.2.3.Italy |
8.2.4.United Kingdom (UK) |
8.2.5.Spain |
9.Asia Pacific (APAC) Contrast Media API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Iohexol |
9.1.2.Iopamidol |
9.1.3.Iodixanol |
9.1.4.Iopromide |
9.1.5.Ioversol |
9.1.6.Diatrizoic acid |
9.1.7.Gadoterate dimeglumine |
9.1.8.Gadobutrol |
9.1.9.Gadobenate dimeglumine Value |
9.1.10.Gadoxetic Acid |
9.1.11.Gadobemedeglumine |
9.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.China |
9.2.2.India |
9.2.3.Australia and New Zealand (ANZ) |
9.2.4.Japan |
9.2.5.Rest of APAC |
10.Middle East and Africa (MEA) Contrast Media API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Iohexol |
10.1.2.Iopamidol |
10.1.3.Iodixanol |
10.1.4.Iopromide |
10.1.5.Ioversol |
10.1.6.Diatrizoic acid |
10.1.7.Gadoterate dimeglumine |
10.1.8.Gadobutrol |
10.1.9.Gadobenate dimeglumine Value |
10.1.10.Gadoxetic Acid |
10.1.11.Gadobemedeglumine |
10.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.GCC Countries |
10.2.2.South Africa |
10.2.3.Rest of MEA |
11.Latin America Contrast Media API Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Iohexol |
11.1.2.Iopamidol |
11.1.3.Iodixanol |
11.1.4.Iopromide |
11.1.5.Ioversol |
11.1.6.Diatrizoic acid |
11.1.7.Gadoterate dimeglumine |
11.1.8.Gadobutrol |
11.1.9.Gadobenate dimeglumine Value |
11.1.10.Gadoxetic Acid |
11.1.11.Gadobemedeglumine |
11.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Brazil |
11.2.2.Mexico |
11.2.3.Rest of LA |
12. Competition Landscape |
12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
12.2.1.GE |
12.2.2.Divi’s Laboratories |
12.2.3.Starry Pharma |
12.2.4.Hovione |
12.2.5.Brother Technology |
12.2.6.Bracco (Innovator) |
12.2.7.DongKook Pharmaceutical Co Ltd |
12.2.8.Pfizer (Hospira) |
12.2.9.Hengrui Pharmaceuticals |
12.2.10.Jiangsu Yutian Pharmaceutical |
12.2.11.Guerbet |
12.2.12.Jiangsu Hengrui Pharmaceuticals |
12.2.13.Haichang Pharmaceutical |
12.2.14.Bayer |
12.2.15.Sichuan Renan Pharmaceutical |
12.2.16.Daewoong Pharma |
12.2.17.Zhejiang Taizhou Hisyn Pharmaceutical |
13. Research Methodology |
14. Appendix and Abbreviations |
Key Market Players